Subcutaneous cavernous hemangioma visualized on an indium-111-octreotide scan release_usu4czghlvfnpl5rpatykdhpji

by P F Winter, J Lapke, R Winek

Published in Journal of Nuclear Medicine.

1996   Volume 37, Issue 9, p1516-7

Abstract

Indium-111-octreotide, a somatostatin analog is the first commercially available receptor-based agent. It shares the binding site of naturally occurring somatostatin and is suitable for imaging somatostatin receptor-bearing tumors. An 111In-octreotide scan performed on a 6-wk old girl showed increased uptake in a subcutaneous cavernous hemangioma, which should be added to the list of lesions that can be visualized on an octreotide scan.
In text/plain format

Archived Files and Locations

application/pdf  897.6 kB
file_qpbi65lr2bejdps54yzdmwgfs4
jnm.snmjournals.org (web)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Year   1996
Language   en ?
PubMed  8790204
Journal Metadata
Not in DOAJ
In Keepers Registry
ISSN-L:  0161-5505
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: bca1ac69-dc3b-43d7-9d83-23df28a2ca39
API URL: JSON